CMIC’s  Hong Kong office was established in 2015 to provide full operational services in the execution of clinical trials under the Pharmaceutical Value Creator (PVC) model. With more than 4 years’ experience in Hong Kong for projects of global and local scales, we understand the region’s biopharmaceutical and healthcare markets.

Our combination of industry experience and expertise across a broad spectrum of therapeutic areas and phases can help you accelerate clinical and commercial success to deliver better medicines, sooner.

Hong Kong is densely populated, allowing for a fewer number of sites to be setup. The country also has a developed infrastructure with a strong presence of academic institutions, but this also causes competition between trials. CMIC is connected to multiple sites in order to best identify qualifying sites for each trial’s unique traits.

Services

  • Regulatory consultation and dossier submission to health authorities (HA) and ethics committees (EC)
  • Clinical monitoring and site management
  • Full Biometrics support and Clinical Study Report (CSR) writing
  • Pharmacovigilance and medical monitoring
  • Quality assurance and quality compliance services
  • Project/Vendor Management

Facility Contact Information

Room 1302, 13/F., Chevalier House, 45-51 Chatham Road South, Tsimshatsui, Kowloon, Hong Kong

Tel: +852 9558 7593

Business Inquires
Email: information@cmic.co.jp

Careers

Asia Clinical Trials

Regulatory Consulting

Pharmacovigilance

Quality Assurance